Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.

Peiris PM, Toy R, Abramowski A, Vicente P, Tucci S, Bauer L, Mayer A, Tam M, Doolittle E, Pansky J, Tran E, Lin D, Schiemann WP, Ghaghada KB, Griswold MA, Karathanasis E.

J Control Release. 2014 Jan 10;173:51-8. doi: 10.1016/j.jconrel.2013.10.031. Epub 2013 Nov 2.

2.

Multicomponent nanochains for treating cancer micrometastasis.

Park K.

J Control Release. 2014 Jan 10;173:166. doi: 10.1016/j.jconrel.2013.12.004. No abstract available.

PMID:
24365051
3.

On-command drug release from nanochains inhibits growth of breast tumors.

Peiris PM, Tam M, Vicente P, Abramowski A, Toy R, Bauer L, Mayer A, Pansky J, Doolittle E, Tucci S, Schmidt E, Shoup C, Rao S, Murray K, Gopalakrishnan R, Keri RA, Basilion JP, Griswold MA, Karathanasis E.

Pharm Res. 2014 Jun;31(6):1460-8. doi: 10.1007/s11095-013-1102-8. Epub 2013 Aug 9.

4.

Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis.

Peiris PM, Deb P, Doolittle E, Doron G, Goldberg A, Govender P, Shah S, Rao S, Carbone S, Cotey T, Sylvestre M, Singh S, Schiemann WP, Lee Z, Karathanasis E.

J Pharm Sci. 2015 Aug;104(8):2600-10. doi: 10.1002/jps.24518. Epub 2015 Jun 2.

5.

Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.

Peiris PM, Abramowski A, Mcginnity J, Doolittle E, Toy R, Gopalakrishnan R, Shah S, Bauer L, Ghaghada KB, Hoimes C, Brady-Kalnay SM, Basilion JP, Griswold MA, Karathanasis E.

Cancer Res. 2015 Apr 1;75(7):1356-65. doi: 10.1158/0008-5472.CAN-14-1540. Epub 2015 Jan 27.

6.

Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.

Bailey-Downs LC, Thorpe JE, Disch BC, Bastian A, Hauser PJ, Farasyn T, Berry WL, Hurst RE, Ihnat MA.

PLoS One. 2014 May 30;9(5):e98624. doi: 10.1371/journal.pone.0098624. eCollection 2014.

7.

Identification of novel drugs to target dormant micrometastases.

Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon LY, Ihnat MA.

BMC Cancer. 2015 May 14;15:404. doi: 10.1186/s12885-015-1409-4.

8.

Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system.

Wang X, Teng Z, Wang H, Wang C, Liu Y, Tang Y, Wu J, Sun J, Wang H, Wang J, Lu G.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1337-47. eCollection 2014.

9.

Nanoparticle delivery for metastatic breast cancer.

Grobmyer SR, Zhou G, Gutwein LG, Iwakuma N, Sharma P, Hochwald SN.

Nanomedicine. 2012 Sep;8 Suppl 1:S21-30. doi: 10.1016/j.nano.2012.05.011. Epub 2012 May 26. Review.

PMID:
22640908
10.

Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.

Wang H, Zhao Y, Wang H, Gong J, He H, Shin MC, Yang VC, Huang Y.

J Control Release. 2014 Oct 28;192:47-56. doi: 10.1016/j.jconrel.2014.06.051. Epub 2014 Jul 6.

PMID:
25003794
11.

Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

Peiris PM, Bauer L, Toy R, Tran E, Pansky J, Doolittle E, Schmidt E, Hayden E, Mayer A, Keri RA, Griswold MA, Karathanasis E.

ACS Nano. 2012 May 22;6(5):4157-68. doi: 10.1021/nn300652p. Epub 2012 Apr 13.

12.

Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation.

Wu H, Cabral H, Toh K, Mi P, Chen YC, Matsumoto Y, Yamada N, Liu X, Kinoh H, Miura Y, Kano MR, Nishihara H, Nishiyama N, Kataoka K.

J Control Release. 2014 Sep 10;189:1-10. doi: 10.1016/j.jconrel.2014.06.018. Epub 2014 Jun 20.

PMID:
24956488
13.

Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.

Abedin F, Anwar MR, Asmatulu R, Yang SY.

J Biomater Appl. 2015 Jul;30(1):38-49. doi: 10.1177/0885328215569614. Epub 2015 Jan 30.

PMID:
25638169
14.

Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.

Zhang L, Zhang S, Ruan SB, Zhang QY, He Q, Gao HL.

Acta Pharmacol Sin. 2014 Jun;35(6):846-52. doi: 10.1038/aps.2014.26.

15.

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.

Swaminathan SK, Roger E, Toti U, Niu L, Ohlfest JR, Panyam J.

J Control Release. 2013 Nov 10;171(3):280-7. doi: 10.1016/j.jconrel.2013.07.014. Epub 2013 Jul 18.

PMID:
23871962
16.

An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform.

Wang W, Song H, Zhang J, Li P, Li C, Wang C, Kong D, Zhao Q.

J Control Release. 2015 Apr 10;203:57-66. doi: 10.1016/j.jconrel.2015.02.015. Epub 2015 Feb 12.

PMID:
25683618
17.

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment.

Deng ZJ, Morton SW, Ben-Akiva E, Dreaden EC, Shopsowitz KE, Hammond PT.

ACS Nano. 2013 Nov 26;7(11):9571-84. doi: 10.1021/nn4047925. Epub 2013 Oct 21.

18.

Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.

Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X.

Acta Biomater. 2015 May;18:132-43. doi: 10.1016/j.actbio.2015.02.022. Epub 2015 Feb 28.

PMID:
25735801
19.

Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.

Subia B, Dey T, Sharma S, Kundu SC.

ACS Appl Mater Interfaces. 2015 Feb 4;7(4):2269-79. doi: 10.1021/am506094c. Epub 2015 Jan 20.

PMID:
25557227
20.

CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.

Zhao Y, Zhang T, Duan S, Davies NM, Forrest ML.

Nanomedicine. 2014 Aug;10(6):1221-30. doi: 10.1016/j.nano.2014.02.015. Epub 2014 Mar 15.

Supplemental Content

Support Center